ETV5 links the FGFR3 and Hippo signalling pathways in bladder cancer
Abstract Activating mutations of fibroblast growth factor receptor 3 (FGFR3) are common in urothelial carcinoma of the bladder (UC). Silencing or inhibition of mutant FGFR3 in bladder cancer cell lines is associated with decreased malignant potential, confirming its important driver role in UC. Howe...
Guardado en:
Autores principales: | Erica di Martino, Olivia Alder, Carolyn D. Hurst, Margaret A. Knowles |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7bb60571b5e24f2aa7be8f839790e504 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Hippo Signaling Pathway: The Trader of Tumor Microenvironment
por: Duo Yang, et al.
Publicado: (2021) -
Mechanosensing and the Hippo Pathway in Microglia: A Potential Link to Alzheimer’s Disease Pathogenesis?
por: Lucrezia Bruno, et al.
Publicado: (2021) -
Glucocorticoids induce osteonecrosis of the femoral head through the Hippo signaling pathway
por: Li Yugang, et al.
Publicado: (2021) -
The Hippo signalling pathway maintains quiescence in Drosophila neural stem cells
por: Rouven Ding, et al.
Publicado: (2016) -
A protein tertiary structure mimetic modulator of the Hippo signalling pathway
por: Hélène Adihou, et al.
Publicado: (2020)